Normalization of ventricular repolarization with flecainide in Long QT Syndrome patients with SCN5A:ΔKPQ mutation

Annals of Noninvasive Electrocardiology

Volumn 6, Issue 2, 2001, Pages 153-158

  Windle, John R ^a,d   Geletka, Robin C ^a   Moss, Arthur J ^b   Zareba, Wojciech ^b   Atkins, Dianne L ^c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Antiarrhythmia agents; Genetics; Ion channels; Long QT syndrome

Indexed keywords

FLECAINIDE; NADOLOL; PROPRANOLOL; SODIUM CHANNEL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFICACY; ELECTROCARDIOGRAM; GENE MUTATION; HEART REPOLARIZATION; HUMAN; LONG QT SYNDROME; PRIORITY JOURNAL; SODIUM CURRENT; T WAVE; TREATMENT OUTCOME;

EID: 0035022511     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2001.tb00100.x     Document Type: Article

References (21)

1. The long QT syndrome: Prospective longitudinal study of 328 families
2. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene
3. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
4. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
5. SCN5A mutations asso ciated with an inherited cardiac arrhythmia, long QT syndrome
6. Mutations in the hminK gene cause long QT syndrome and suppress IKs function
7. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia
8. Multiple mechanisms of Na+ channel-linked long-QT syndrome
9. A de novo missense mutation (R1623Q) of the SCN5A gene in a Japanese girl with sporadic long QT syndrome. Mutations in brief no. 140. Online
10. Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel
11. Molecular mechanism for an inherited cardiac arrhythmia
12. Electrocardiographic T-wave patterns in genetically distinct forms of the hereditary long-QT syndrome
13. + channel blockade and to increases in heart rate: Implications for gene-specific therapy
14. Gene-specific therapy for long QT syndrome: QT shortening with lidocaine and tocainide in patients with mutation of the sodium channel gene
15. Effects of flecainide in patients with a new SCN5A mutation: Mutation-specific therapy for long QT syndrome?
16. Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and betal-subunits
17. Preferential block of late sodium current in the LQT3 ΔKPQ Mutant by the class Ic antiarrhythmic flecainide
18. Flecainide
19. Mortality and morbidity in patients randomized to receive encainide, flecainide, or placebo in the Cardiac Arrhythmia Suppression Trial
20. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
21. A single sodium channel mutation causing both long QT- and Brugada syndrome